Vireo Growth Inc. Files 8-K with Key Disclosures
Ticker: VREOF · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1771706
| Field | Detail |
|---|---|
| Company | Vireo Growth Inc. (VREOF) |
| Form Type | 8-K |
| Filed Date | Nov 3, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $10 million, $1 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Vireo Growth Inc. dropped an 8-K on Oct 29th - check it for Reg FD, other events, and financials.
AI Summary
Vireo Growth Inc. filed an 8-K on November 3, 2025, reporting events that occurred on October 29, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Vireo Health International, Inc. and Goodness Growth Holdings, Inc., is incorporated in British Columbia and headquartered in Minneapolis, Minnesota.
Why It Matters
This 8-K filing provides updates on important company events and financial information, which are crucial for investors to assess the current status and future prospects of Vireo Growth Inc.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant corporate events, and their impact on the company's stock price can be substantial, warranting a medium risk assessment.
Key Players & Entities
- Vireo Growth Inc. (company) — Registrant
- October 29, 2025 (date) — Earliest event reported
- November 3, 2025 (date) — Date of report
- Vireo Health International, Inc. (company) — Former company name
- Goodness Growth Holdings, Inc. (company) — Former company name
- Minneapolis, Minnesota (location) — Principal executive offices
FAQ
What specific events are disclosed under 'Other Events' in this 8-K filing?
The filing indicates 'Other Events' as a category, but the specific details of these events are not provided in the excerpt.
When was Vireo Growth Inc. previously known as Vireo Health International, Inc.?
The filing states the date of the name change from Vireo Health International, Inc. to Vireo Growth Inc. was March 26, 2019.
What is the principal executive office address for Vireo Growth Inc.?
The principal executive offices are located at 207 South 9th Street, Minneapolis, Minnesota 55402.
What is the SIC code for Vireo Growth Inc.?
The Standard Industrial Classification (SIC) code for Vireo Growth Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the earliest event date reported in this 8-K filing?
The earliest event reported in this 8-K filing is October 29, 2025.
Filing Stats: 603 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-11-03 16:06:11
Key Financial Figures
- $10 million — ement to the Company is approximately US$10 million consisting of the acquisition of certai
- $1 million — ion of certain real estate assets and US$1 million in cash. Item 9.01. Financial Statemen
Filing Documents
- tm2530016d1_8k.htm (8-K) — 26KB
- tm2530016d1_ex99-1.htm (EX-99.1) — 13KB
- 0001104659-25-105541.txt ( ) — 202KB
- gdnsf-20251029.xsd (EX-101.SCH) — 3KB
- gdnsf-20251029_lab.xml (EX-101.LAB) — 33KB
- gdnsf-20251029_pre.xml (EX-101.PRE) — 22KB
- tm2530016d1_8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On October 29, 2025, Vireo Growth Inc. (the "Company") issued a press release announcing the Settlement Agreement (as defined below). A copy of the Company's press release is furnished as Exhibit 99.1 hereto and is incorporated by reference herein. The information contained in this Item 7.01 and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor will such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
01. Other Events
Item 8.01. Other Events On October 29, 2025, the Company announced that it had entered into a comprehensive settlement (the "Settlement Agreement") dismissing all outstanding litigation matters between the Company and Verano Holdings Corp. ("Verano") that are pending before the Supreme Court of British Columbia, Canada. Commenced on October 21, 2022, the litigation related to the January 31, 2022 arrangement agreement between the Company and Verano. The Company's Board of Directors approved the terms of the settlement. The value of the settlement to the Company is approximately US$10 million consisting of the acquisition of certain real estate assets and US$1 million in cash.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated October 29, 2025* 104 Cover Page Interactive Data File (embedded within Inline XBRL document) *Furnished herewith
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIREO GROWTH INC. (Registrant) Date: November 3, 2025 By: /s/ Tyson Macdonald Tyson Macdonald Chief Financial Officer